Scarica l'app Stockscreener
7.10
3.65%
0.25
Dopo l'orario di chiusura:
7.11
0.01
+0.14%
Precedente Chiudi:
$6.85
Aprire:
$6.85
Volume 24 ore:
10,009
Relative Volume:
0.05
Capitalizzazione di mercato:
$4.09M
Reddito:
$49,300
Utile/perdita netta:
$-6.27M
Rapporto P/E:
-0.7811
EPS:
-9.09
Flusso di cassa netto:
$-5.38M
1 W Prestazione:
+1.14%
1M Prestazione:
-19.41%
6M Prestazione:
+39.13%
1 anno Prestazione:
-12.29%
Intervallo 1D:
$6.85
$7.10
Intervallo di 1 settimana:
$6.78
$7.54
Portata 52W:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Confronta ACON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
7.10 | 4.09M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Borsa (ACON) Ultime notizie
Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News
Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan
Aclarion secures funding for pivotal CLARITY trial - MSN
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News
Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus
Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks
Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq
Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan
Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com
Aclarion Releases Updated Investor Presentation at Showcase - TipRanks
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times
Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph
Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News
Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq
New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan
NOCISCAN touted as lumbar pain diagnostic advance - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times
Aclarion, Inc. SEC 10-K Report - TradingView
Healthcare AI Pioneer Aclarion Reveals Growth Strategy at Major Vegas Investor Summit - Stock Titan
Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada
Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion ‘s Nociscan now available in Santa Monica at MICSC - TipRanks
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - The Manila Times
EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?Apple (NASDAQ:AAPL), Aclarion (NASDAQ:ACON) - Benzinga
Aclarion, Inc. Delays Annual Report Filing - TipRanks
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - Ortho Spine News
Aclarion provides corporate update following Q1 strategic initiatives - TipRanks
Aclarion, Inc. (NASDAQ:ACON) Short Interest Down 73.9% in March - Defense World
Aclarion stock plunges to 52-week low of $0.51 amid steep decline By Investing.com - Investing.com South Africa
Aclarion announces 1-for-27 reverse stock split By Investing.com - Investing.com South Africa
Aclarion Announces Reverse Stock Split - OrthoSpineNews
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings - Benzinga
Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga
Aclarion stock plunges to 52-week low of $0.51 amid steep decline - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Aclarion announces 1-for-27 reverese stock split - TipRanks
Aclarion announces 1-for-27 reverse stock split - Investing.com
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.13%
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):